HPY-19974-91741
3 vaccinations
6 coded responses
26 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 181 / PA
- Registered
- 2022-06-28
- Relationship
- Child or adolescent in my care
- Guardian
- BBE-21815-51127
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Dose 1 — Moderna
-
2022-06-28
Registered in v-safe
-
2022-06-30
Survey response — days 1–6 daily, dose 1, dependentMedDRA: No adverse event — Feeling: GoodFree text: (b)(6) has experienced no adverse effects on the previous days eitherMedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
- 2022-07-03
-
2022-07-06
Health check-in — day 7, dose 1, dependentFeeling: Good · Site: Redness · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2022-07-06
Report sent to call center — day 7, dose 1, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-07
-
2022-07-07
Call successfulParticipant prefers to complete VAERS report online
- 2022-07-11
- 2022-07-18
- 2022-07-26
- 2022-08-01
-
2022-08-08
Dose 2 — Moderna
-
2022-08-09
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2022-08-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2022-08-15
- 2022-08-22
- 2022-08-29
-
2022-09-05
Survey response — day 28, dose 2, dependentMedDRA: Cough, Malaise, Pyrexia, Respiratory symptom — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory signs, low fever, coughCOVID symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-05
Report sent to call center — day 28, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-07
- 2022-09-14
-
2022-09-20
Survey response — day 42, dose 2, dependentMedDRA: Unevaluable event — Feeling: Good · Be unable to work or attend schoolFree text: Upper respiratoryMedDRA releases: 2024-11 · check-in free text available
-
2022-11-01
Dose 3 — Pfizer-BioNTech
- 2022-11-01
-
2022-11-02
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Body temperature increased — Feeling: Fair · Site: PainFree text: Elevated temp to about 99.7 FMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-11-06
- 2022-11-07
-
2022-11-16
Survey response — day 14, dose 3, dependentMedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Report sent to call center — day 14, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-17
- 2022-11-17
- 2022-11-22
- 2022-11-30
- 2022-12-09
-
2022-12-16
Survey response — day 42, dose 3, dependentMedDRA: Nasal congestion — Feeling: Good · Be unable to work or attend schoolFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Moderna | No |
| 2 | 2022-08-08 | Moderna | No |
| 3 | 2022-11-01 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 successful · 2 unsuccessful
Free text
Release 12 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): (b)(6) has experienced no adverse effects on the previous days either
redacted (b)(6)
Release 12 — day 28, dose 2, dependent
Symptoms: Upper respiratory signs, low fever, coughCOVID symptoms
Release 12 — day 42, dose 2, dependent
Symptoms: Upper respiratory
Release 12 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Elevated temp to about 99.7 F
Release 12 — day 14, dose 3, dependent
Symptoms: RSV infection
Release 12 — day 42, dose 3, dependent
Symptoms: Nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release